Use of eculizumab in atypical hemolytic uremic syndrome associated with impaired renal function: integrative review. Arq. Ciên. Saud. [Internet]. 2022 Dec. 16 [cited 2025 Apr. 3];26(1):72-5. Available from: https://ahs.famerp.br/index.php/ahs/article/view/101